Corvus Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Corvus Pharmaceuticals | 8-K: Current report
Corvus Pharmaceuticals | 8-K: Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
Corvus Pharmaceuticals | 8-K: Current report
Corvus Pharmaceuticals | DEFA14A: Others
Corvus Pharmaceuticals | DEF 14A: Definitive information statements
Corvus Pharmaceuticals | 8-K: Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Corvus Pharmaceuticals | 8-K: Current report
Corvus Pharmaceuticals | 8-K: Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
Corvus Pharmaceuticals | 8-K: Current report
Corvus Pharmaceuticals | 8-K: Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
Corvus Pharmaceuticals | 8-K: Current report
Corvus Pharmaceuticals | 8-K: Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
Corvus Pharmaceuticals | DEFA14A: Others
Corvus Pharmaceuticals | DEF 14A: Definitive proxy statements
Corvus Pharmaceuticals | 8-K: Current report
Corvus Pharmaceuticals | 8-K: Current report
Corvus Pharmaceuticals | 8-K: Current report
Corvus Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Corvus Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data